Reactome | Lahr, A

Schema > Person > Entries

created	[InstanceEdit:9685099] Jassal, Bijay, 2020-04-22
dbId	9685041
displayName	Lahr, A
firstname	Angelika
initial	A
publications	[LiteratureReference:9685083] First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors [LiteratureReference:9685091] The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)
schemaClass	Person
surname	Lahr

Cite Us!